Acrux Limited (ARUXF)
OTCMKTS · Delayed Price · Currency is USD
0.0045
-0.0118 (-72.39%)
At close: Jan 8, 2026
Acrux Market Cap
Acrux has a market cap or net worth of $4.38 million as of February 12, 2026. Its market cap has decreased by -42.43% in one year.
Market Cap
4.38M
Enterprise Value
6.36M
Revenue
780.17K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since September 29, 2004, Acrux's market cap has decreased from 64.88M to 4.38M, a decrease of -93.24%. That is a compound annual growth rate of -11.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 4.38M | 6.71% |
| Dec 31, 2025 | 4.11M | -49.99% |
| Dec 31, 2024 | 8.21M | -5.44% |
| Dec 29, 2023 | 8.69M | -36.25% |
| Dec 30, 2022 | 13.63M | -33.94% |
| Dec 31, 2021 | 20.63M | -23.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BetterLife Pharma | 6.49M |
| Brainstorm Cell Therapeutics | 6.46M |
| GPL Holdings | 5.83M |
| Bioxytran | 5.56M |
| LakeShore Biopharma | 5.33M |
| Clearside Biomedical | 5.10M |
| AXIM Biotechnologies | 4.99M |
| Enzon Pharmaceuticals | 4.79M |